Search Count: 24
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2023-03-15 Classification: VIRAL PROTEIN Ligands: DMS, 35J, NA |
 |
Crystal Structure Of The Sars-Cov-2 Main Protease Complexed With N-(Pyridin-3-Ylmethyl)Thioformamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2022-03-02 Classification: VIRAL PROTEIN Ligands: 35J, NA, FMT, DMS |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2021-10-06 Classification: VIRAL PROTEIN Ligands: DMS, GOL, FMT |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2021-10-06 Classification: VIRAL PROTEIN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.73 Å Release Date: 2015-10-07 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, 2H7, 1PE, PEG, EDO, EPE, DIO |
 |
Crystal Structure Of Human Insulin Degrading Enzyme (Ide) In Complex With Compound 71290
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.91 Å Release Date: 2015-09-30 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, 3M9, EPE, PEG, 1PE, EDO |
 |
Crystal Structure Of Human Insulin Degrading Enzyme (Ide) In Complex With Inhibitor N-Benzyl-N-(Carboxymethyl)Glycyl-L-Histidine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2015-05-13 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 33K, ZN |
 |
Crystal Structure Of The M. Tuberculosis Sulfate Ester Dioxygenase Rv3406 In Complex With Iron.
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2014-12-10 Classification: OXIDOREDUCTASE Ligands: NO3, FE |
 |
Crystal Structure Of M. Tuberculosis Dpre1 In Complex With The Non-Covalent Inhibitor Qn127
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2014-12-10 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FAD, Y22, IMD, 2J3 |
 |
Crystal Structure Of M. Tuberculosis Dpre1 In Complex With The Non-Covalent Inhibitor Ty38C
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2014-12-10 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FAD, 38C |
 |
Crystal Structure Of M. Tuberculosis Dpre1 In Complex With The Non-Covalent Inhibitor Ty36C
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2014-12-10 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FAD, 36C, IMD |
 |
Crystal Structure Of M. Tuberculosis Dpre1 In Complex With The Non-Covalent Inhibitor Qn114
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2014-12-10 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FAD, R58, 2J3, IMD |
 |
Crystal Structure Of M. Tuberculosis Dpre1 In Complex With The Non-Covalent Inhibitor Qn118
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2014-12-10 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FAD, R57, IMD |
 |
Crystal Structure Of M. Tuberculosis Dpre1 In Complex With The Non-Covalent Inhibitor Qn127
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2014-12-10 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FAD, RG2, 2J3, IMD |
 |
Crystal Structure Of M. Tuberculosis Dpre1 In Complex With The Non-Covalent Inhibitor Qn129
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2014-12-10 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FAD, R26, IMD, 2J3 |
 |
Crystal Structure Of M. Tuberculosis Dpre1 In Complex With The Non-Covalent Inhibitor Ty21C
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2014-12-10 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FAD, 38C, IMD |
 |
Crystal Structure Of Human Insulin Degrading Enzyme (Ide) In Complex With Compound Bdm44619
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.29 Å Release Date: 2013-12-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, 1EF |
 |
Structure Analysis Of Cysteine Free Insulin Degrading Enzyme (Ide) With Compound Bdm43079 [{[(S)-2-(1H-Imidazol-4-Yl)-1-Methylcarbamoyl-Ethylcarbamoyl]-Methyl}-(3-Phenyl-Propyl)-Amino]-Acetic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.99 Å Release Date: 2013-08-28 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: MGJ, ZN |
 |
Structure Analysis Of Insulin Degrading Enzyme With Compound Bdm41559 ((S)-2-[2-(Carboxymethyl-Phenethyl-Amino)-Acetylamino]-3-(1H-Imidazol-4-Yl)-Propionic Acid Methyl Ester)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.81 Å Release Date: 2013-08-28 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, MGW |
 |
The Structure Analysis Of Cysteine Free Insulin Degrading Enzyme (Ide) With (S)-2-{2-[Carboxymethyl-(3-Phenyl-Propionyl)-Amino]-Acetylamino}-3-(3H-Imidazol-4-Yl)-Propionic Acid Methyl Ester
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2013-08-28 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: MGH, ZN |